FDA's Nonprescription Drugs Advisory Committee and Pulmonary-Allergy Drugs Advisory Committee to Meet and Seek Public Feedback

Summary

The US Food and Drug Administration (FDA) has scheduled a meeting of its Nonprescription Drugs Advisory Committee and Pulmonary-Allergy Drugs Advisory Committee to discuss various topics, and is now seeking public comments on the agenda and proposed schedule.